Search - tctmd.com

Displaying 41 - 60 of 81

Presentation The Structural Heart Disease Summit 2018

Case #1: A Poorly Visible Surgical Bioprosthesis

Presenter: Isaac George, Adnan K. Chhatriwalla, Danny Dvir, Ariel Finkelstein, Kendra J. Grubb, Michael J. Mack, Thomas Modine, Mark J. Russo

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

A Tutorial on Surgical Bioprosthesis Design: Impact on ViV Therapy

Presenter: Vinayak Bapat, Ran Kornowski

June 21, 2018

News Daily News

Preexisting Prosthesis-Patient Mismatch Signals Worse Aortic Valve-in-Valve Outcomes

Todd Neale

January 17, 2018

News Conference News AHA 2017

More Support for TMVR After Failed Mitral Bioprostheses

Yael L. Maxwell

November 23, 2017

News Conference News ESC 2017

European Societies Issue New Valvular Heart Disease Guidelines, With Important Shifts

Shelley Wood

August 27, 2017

Presentation TVT 2017

The Use and Potential Advantages of Alternative TAVR Systems for Treating Aortic Bioprosthesis Failure (Acurate, Lotus, and Portico)

Presenter: Ran Kornowski, Mark J. Russo, Danny Dvir

June 15, 2017

Presentation TVT 2017

Expert Commentary: Evolut R in Degenerative Surgical Aortic Bioprostheses (VIVA Registry)

Presenter: Ran Kornowski

June 15, 2017

Presentation TVT 2017

Case Outcome

Presenter: Molly Szerlip

June 15, 2017

Presentation TVT 2017

Expert Commentary: VIVID Registry and Technical Aspects

Presenter: Neil E. Moat

June 15, 2017

Presentation TVT 2017

Case Presentation: A Case of Valve-in-Valve TAVR in a Stentless Bioprosthesis

Presenter: Molly Szerlip

June 15, 2017

Presentation TVT 2017

Case Presentation: Aortic Surgical Bioprosthesis Failure and Expert Commentary: A Step-by-Step Approach and How to Use the ViV Aortic App

Presenter: Vinayak Bapat, Torsten P. Vahl

June 15, 2017

News Conference News EuroPCR 2017

TAVR Durability: Some Reassurances From CoreValve Trials Out to 9 Years

Caitlin E. Cox

May 17, 2017

News Daily News

Updated PARTNER 2 Valve-in-Valve Registry: More Experience, Better Outcomes

Shelley Wood

May 02, 2017

News Opinion Editor's Corner TCT 2015

My Takeaways From TCT 2015

Shelley Wood

October 20, 2015

News Daily News

Many Heart Failure Patients Reap QoL Gain From TAVR Despite High Mortality

January 12, 2015

News Daily News

Preexisting—But Not New-Onset—A-fib Predicts Worse Long-term Outcomes After TAVR

October 17, 2014

News Daily News

Incomplete Revascularization Linked to Poorer Outcomes in TAVR Patients With CAD

September 11, 2014

News Daily News

VIVID Registry: Benefit of Valve-in-Valve TAVR Depends on Size, Status of Failed Surgical Bioprosthesis

July 10, 2014

News Conference News EuroPCR 2014

EuroPCR 2014: Clinical Challenges, Novel Innovations Share the Limelight

Caitlin E. Cox

May 28, 2014

News Conference News EuroPCR 2014

Studies Document Initial Steps Toward Percutaneous Mitral Valve Replacement

Caitlin E. Cox

May 23, 2014

Advertisement

Case #1: A Poorly Visible Surgical Bioprosthesis

A Tutorial on Surgical Bioprosthesis Design: Impact on ViV Therapy

Preexisting Prosthesis-Patient Mismatch Signals Worse Aortic Valve-in-Valve Outcomes

More Support for TMVR After Failed Mitral Bioprostheses

European Societies Issue New Valvular Heart Disease Guidelines, With Important Shifts

The Use and Potential Advantages of Alternative TAVR Systems for Treating Aortic Bioprosthesis Failure (Acurate, Lotus, and Portico)

Expert Commentary: Evolut R in Degenerative Surgical Aortic Bioprostheses (VIVA Registry)

Case Outcome

Expert Commentary: VIVID Registry and Technical Aspects

Case Presentation: A Case of Valve-in-Valve TAVR in a Stentless Bioprosthesis

Case Presentation: Aortic Surgical Bioprosthesis Failure and Expert Commentary: A Step-by-Step Approach and How to Use the ViV Aortic App

TAVR Durability: Some Reassurances From CoreValve Trials Out to 9 Years

Updated PARTNER 2 Valve-in-Valve Registry: More Experience, Better Outcomes

My Takeaways From TCT 2015

Many Heart Failure Patients Reap QoL Gain From TAVR Despite High Mortality

Preexisting—But Not New-Onset—A-fib Predicts Worse Long-term Outcomes After TAVR

Incomplete Revascularization Linked to Poorer Outcomes in TAVR Patients With CAD

VIVID Registry: Benefit of Valve-in-Valve TAVR Depends on Size, Status of Failed Surgical Bioprosthesis

EuroPCR 2014: Clinical Challenges, Novel Innovations Share the Limelight

Studies Document Initial Steps Toward Percutaneous Mitral Valve Replacement

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content